Insulin glargine and lixisenatide and Vantin (Cefpodoxime Suspension)
Determining the interaction of Insulin glargine and lixisenatide and Vantin (Cefpodoxime Suspension) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: cefpodoxime
Brand name: Vantin
Synonyms: Vantin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Vantin (Cefpodoxime Tablets)
- Insulin glargine and lixisenatide-Vantrela ER
- Insulin glargine and lixisenatide-Vaprisol
- Insulin glargine and lixisenatide-Vaqta
- Insulin glargine and lixisenatide-Vaqta Pediatric
- Insulin glargine and lixisenatide-Vardenafil
- Vantin (Cefpodoxime Suspension)-Insulin glargine and lixisenatide Subcutaneous
- Vantin (Cefpodoxime Suspension)-Insulin glargine, recombinant Subcutaneous
- Vantin (Cefpodoxime Suspension)-Insulin glulisine
- Vantin (Cefpodoxime Suspension)-Insulin Glulisine (Cartridges and Pens)
- Vantin (Cefpodoxime Suspension)-Insulin Glulisine (Vials)
- Vantin (Cefpodoxime Suspension)-Insulin glulisine Subcutaneous